Risk of bias assessment using the criteria from the Cochrane Back Review Group
Study | Item | |||||||||||||
1. Was the method of randomisation adequate? | 2. Was the treatment allocation concealed? | 3. Was the patient blinded to the intervention? | 4. Was the care provider blinded to the intervention? | 5. Was the outcome assessor blinded to the intervention? | 6. Was the drop-out rate described and acceptable? | 7. Were all randomised participants analysed in the group to which they were allocated? | 8. Are reports of the study free of suggestion of selective outcome reporting? | 9. Were the groups similar at baseline regarding the most important prognostic indicators? | 10. Were cointerventions avoided or similar? | 11. Was the compliance acceptable in all groups? | 12. Was the timing of the outcome assessment similar in all groups? | 13. Are other sources of potential bias unlikely? | Score (0/13) | |
Aboagye et al 39 | Unclear | Unclear | No | No | No | No | Yes | Yes | No | Unclear | Unclear | Yes | Yes | 4 |
Bello et al 40 | Yes | Yes | Unclear | No | Unclear | No | Yes | Unclear | Yes | Unclear | No | Yes | Yes | 6 |
Bosmans et al 34 | Yes | Yes | No | No | No | Yes | Yes | No | Yes | Yes | No | Yes | Yes | 8 |
Carr et al 41 | Yes | Unclear | No | No | No | No | Yes | Unclear | Yes | Unclear | No | Yes | Yes | 5 |
Cherkin et al 42 | Yes | Unclear | No | No | No | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | 8 |
Chuang et al 43 | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | 9 |
Critchley et al 44 | Yes | Yes | No | No | No | No | Yes | Yes | Yes | Yes | Unclear | Yes | Yes | 8 |
van Dongen et al 38 | Yes | Yes | No | No | No | No | Yes | No | Yes | Yes | Unclear | Yes | Yes | 7 |
Henchoz et al 45 | Yes | Yes | No | No | No | No | Yes | Yes | Yes | Yes | No | Yes | Yes | 8 |
Hlobil et al 46 | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 10 |
Hollinghurst et al 47 | Yes | Yes | No | No | No | No | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | 8 |
Hurley et al 48 | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | 9 |
Korthals-de Bos et al 35 | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | 9 |
Leininger et al 36 | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 10 |
Manca et al 55 | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 10 |
van der Roer et al 53 | Yes | Yes | No | No | No | Yes | Yes | No | Yes | Yes | No | Yes | Yes | 8 |
Rosenfeld et al 37 | Yes | Unclear | No | No | No | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | 8 |
Seferlis et al 49 | Unclear | Unclear | No | No | No | No | Yes | Yes | Unclear | Unclear | Yes | Yes | Yes | 5 |
Smeets et al 50 | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | Yes | No | Yes | Unclear | 8 |
Torstensen et al 52 | Unclear | Unclear | No | No | No | Yes | Yes | Unclear | Yes | Unclear | Unclear | Yes | Yes | 5 |
UK BEAM51 | Unclear | Yes | No | No | No | No | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | 7 |
Wright et al 54 | Yes | Yes | No | No | No | Yes | No | Unclear | No | Unclear | Unclear | Yes | Yes | 5 |